Repeated Dosing Clinical Trial of HL151

Summary

The purpose of this study is to assess the pharmacokinetic characteristics of bepotastine after multiple oral administration of TALION tab., a IR formulation of bepotastine as reference drug and HL151, a SR formulation of bepotastine as test drug in healthy male adults. Additionally the safety and tolerability of two drugs will be evaluated.

Timeline

Start

2016-02-16

Primary completion

2016-03-15

Completion

2016-03-15

Drugs

Indications